T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
51
People Inc
PPLI
$2.97B
| $2.93B | 0.41% |
75,305,612
+2,983,292
| +4% | +$119M |
|
|
WCN
52
Waste Connections
WCN
$42B
| $2.9B | 0.41% |
30,339,139
+453,728
| +2% | +$41.8M |
|
53
Johnson & Johnson
JNJ
$626B
| $2.9B | 0.41% |
20,791,713
+2,204,757
| +12% | +$305M |
|
54
Chubb
CB
$134B
| $2.9B | 0.41% |
19,659,835
-1,661,025
| -8% | -$240M |
|
55
Texas Instruments
TXN
$257B
| $2.87B | 0.4% |
25,045,313
-4,691,119
| -16% | -$525M |
|
56
Philip Morris
PM
$290B
| $2.85B | 0.4% |
36,351,876
-7,943,608
| -18% | -$656M |
|
57
Fidelity National Information Services
FIS
$22.1B
| $2.75B | 0.39% |
22,412,408
-3,538,149
| -14% | -$416M |
|
58
Honeywell
HON
$72.9B
| $2.72B | 0.38% |
16,517,177
-59,918
| -0.4% | -$9.54M |
|
59
Qualcomm
QCOM
$171B
| $2.67B | 0.38% |
35,136,722
+11,686,131
| +50% | +$856M |
|
|
VMW
60
DELISTED
VMware, Inc
VMW
| $2.64B | 0.37% |
15,779,762
+414,814
| +3% | +$77.7M |
|
61
L3Harris
LHX
$53.3B
| $2.61B | 0.37% |
13,788,083
-789,509
| -5% | -$142M |
|
62
Morgan Stanley
MS
$338B
| $2.61B | 0.37% |
59,486,001
-1,537,284
| -3% | -$68.6M |
|
|
SCHW
63
Charles Schwab
SCHW
$186B
| $2.45B | 0.34% |
60,855,583
-17,022,988
| -22% | -$742M |
|
64
TransUnion
TRU
$15.4B
| $2.41B | 0.34% |
32,735,686
-89,620
| -0.3% | -$6.13M |
|
|
65
Marvell Technology
MRVL
$191B
| $2.34B | 0.33% |
97,954,732
+55,005,127
| +128% | +$1.28B |
|
66
Hilton Worldwide
HLT
$70.8B
| $2.27B | 0.32% |
23,233,493
+3,174,048
| +16% | +$288M |
|
67
Comcast
CMCSA
$91B
| $2.27B | 0.32% |
53,688,862
+4,446,292
| +9% | +$188M |
|
|
MXIM
68
DELISTED
Maxim Integrated Products
MXIM
| $2.25B | 0.32% |
37,680,681
-177,984
| -0.5% | -$10.1M |
|
69
Ross Stores
ROST
$80.8B
| $2.23B | 0.31% |
22,522,025
+3,204,917
| +17% | +$312M |
|
70
Dollar Tree
DLTR
$24.6B
| $2.23B | 0.31% |
20,778,093
+2,816,679
| +16% | +$296M |
|
|
71
Alcon
ALC
$36.7B
| $2.23B | 0.31% |
+36,020,796
| New | +$2.11B |
|
72
ExxonMobil
XOM
$657B
| $2.23B | 0.31% |
29,078,944
-3,593,249
| -11% | -$278M |
|
73
Bank of America
BAC
$448B
| $2.17B | 0.3% |
74,659,166
+19,688,816
| +36% | +$568M |
|
74
Medtronic
MDT
$116B
| $2.16B | 0.3% |
22,211,176
+516,915
| +2% | +$47.2M |
|
75
HCA Healthcare
HCA
$89.1B
| $2.15B | 0.3% |
15,906,139
+1,375,021
| +9% | +$174M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.